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Abstract
Introduction The aim of our study was to determine the
possibility of using a new functional technique: a T1-
dependent sequence with administration of blood pool
contrast agent (BPCA), in patients with brain tumors before
and after surgical treatment. We also aimed to compare our
results with those obtained using the fMRI technique, based
on Blood Oxygenation Level-Dependent (BOLD) contrast.
Methods For each of our 14 oncologic patients (four before
and ten after neurosurgical intervention), we obtained: a T1-
3D GRE sequence (TR=2.6 ms/TE=1.1 ms/FA=10°) after
intravenous administration of BPCA (0.03 mmol/kg), as well
as a T2*EPI sequence (TR=3 s/TE=50 ms/FA=90°).
Movement and/or tactile block type paradigms were carried
out during both functional runs. SPM5 software was used for
analysis.
Results For both functional techniques, maximum activa-
tions were localized in the same areas. There were no
significant differences observed in the t values calculated
for activations located in the primary motor cortex between
groups of pre- and post-intervention patients (in the same
functional technique). The mean values for T2* EPI
examinations were 10.84 and 9.36, respectively. The mean
t values for the T1 technique were lower, especially for the
post-intervention patients (5.83 and 3.9, respectively).
Conclusions The T1 technique can be used to detect
functional areas in patients with brain tumors, pre-, and
post-surgical intervention. This technique enables the
evaluation of cortical centers that suffer from susceptibility
artifacts when using the T2* BOLD technique. Activations
found using both techniques have the same localization,
with lower values for the T1 technique.
Keywords Functional MRI.CBV.Contrast media.Brain
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Introduction
The Blood Oxygenation Level-Dependent (BOLD) effect-
based technique has for years been the most significant and
valuable technique used during the examination of cerebral
center activity. As for every technique, however, it has
some limitation [1–4]. The T2*-weighted echo planar (EPI)
sequences, being the basis for BOLD contrast detection, are
characterized with high sensitivity to magnetic field
heterogeneity. Therefore, adjacent areas that differ signifi-
cantly in terms of magnetic susceptibility may be examined
with fMRI BOLD only provided that specific techniques
are employed [5–7]. If such techniques are not used,
examination of these areas will not be possible due to the
presence of marked artifacts or signal loss. Basal parts of
the frontal lobes, connecting to the paranasal sinuses, as
well as the basal parts of the temporal lobes (which are
located in close proximity to the compact parts of the
petrous bones) represent important regions of the brain
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fMRI BOLD evaluation. Examination of brain regions
located next to clinical lesions and/or post-surgical artifacts
such as scars, vascular clips, stent grafts, or CranioFixes is
another important clinical application of functional studies.
These studies are performed in patients after neurosur-
geries, and particularly in subjects who were operated on
due to brain tumors and are followed up in context of the
relapse [4, 8].
The cerebral blood volume (CBV) technique, based on
T1-weighted sequences, constitutes an alternative to fMRI
BOLD used in the examination of cerebral center activity.
This method utilizes T1-dependent sequences. The advan-
tages of this novel technique which are of special meaning
are: better signal to noise ratio, smaller artifacts due to large
venous vessels, high spatial resolution, and more localized
and at the same time highly specific mapping of the brain
activations [9–12]. Clinical applications of novel contrast
agents, namely blood pool contrast agents (BPCA), enable
the use of CBV in the functional evaluation of healthy
volunteers and patients [11, 13–18]. However, no studies
have been performed thus far describing the usefulness of
this technique in the localization of active cerebral centers
in neurosurgical patients.
The aim of this study was to verify the usefulness of the
sensitive T1-weighted sequence along with blood pool
contrast agents, when establishing functional maps of
eloquent cortical regions in brain tumor patients before
and after neurosurgeries. Moreover, the efficacy of the
aforementioned method was compared to the standard
functional MRI technique based on BOLD contrast.
Materials and methods
Four patients (14–58 years of age; mean age of 25.7; one
female, three males), with a diagnosis of central nervous
system tumors based on prior computer tomography and
MRI examinations were included in the first group. All of
these subjects were qualified for surgical treatment and
subsequently underwent surgical interventions.
The second group consisted of ten patients (23–58 years
of age; mean age of 42.2; four females, six males) who had
previously undergone neurosurgical interventions for brain
tumors; in five cases, the subjects had been diagnosed with
recurrent tumors. Of the ten patients, seven had previously
undergone one surgical operation, two had undergone two
interventions, and one had undergone three interventions.
The patients in this group underwent the following surgical
procedures: one had undergone a partial resection, three had
had a subtotal resection, with the remaining six patients
having undergone total resections of the tumors. All the
procedures were performed from 3 days to 91 months prior
to the functional examinations included into this study.
Detailed data is presented in Table 1.
The ethics committee at our institution approved these
procedures, which were conducted in accordance to the
principles established by the Helsinki Convention. In-
formed consent was obtained from all participants.
Examinations were performed using a 1.5-T scanner,
Avanto, Syngo ver. N4VB13A with 12ch HeadMatrix coil,
Siemens, Germany. Both EPI sequences, as well as T1 spin
echo (SE) were performed using standard parameters
routinely used in clinical practice. First, a high-resolution
T1 anatomical scan was performed with 1×1×1 mm
isotropic voxels. A three-dimensional FLASH sequence
was obtained according to the following protocol: FOV=
256×256 mm, matrix=256×256, TR=8.8 ms, TE=4.8 ms,
FA=25°, TA=5′07. Each volume acquired contained 160
slices, 1 mm thick, with no gap. Next, a reference scan (run
1) was acquired with a typical T2*-sensitive GRE EPI
sequence: TR=3000 ms, TE=50 ms, FA=90 deg, FOV=
240×240 mm, iPAT=2, pixel bandwidth =2605 Hz/Px, for
38 3-mm thick slices with 0.75 mm gap and 3.75 mm in-
plane resolution. All slices where positioned in the axial
plane parallel to the AC-PC line. One hundred volumes
were acquired with total TA=5′12 (four dummy scans).
BPCA was administrated in the second part of the
examinations. MS-325, at the time of our study produced as
Vasovist™ (Bayer Schering Pharma, Berlin), now known as
Ablavar™ (Lantheus Medical Group), is a contrast agent
containing a chelate of gadolinium diethylenetriaminepentaa-
cetato with a (diphenylcyclohexyl) phosphono-oxymethyl
substituent (Gadofosveset Trisodium) at a concentration of
0.25 mmol/ml. Following intravenous administration, it
reversibly binds to albumin plasma protein (80–87%), thus
extending plasma half-life (0.48±0.1 h for t_1/2_alpha-half-
life for distribution phase, and ~16 h for t_1/2_beta-half-life
for the elimination phase) and limiting its movement out of
bloodvessels.Therelaxationvalueoftheplasmaat20MHzis
calculated between 33.4 and 45.7 mM
−1 s
−1 for doses of
0.05 mmol/kg mc [19–21]. Both these characteristics
underline the value of MS-325 for fMRI with T1-
dependent sequences [22]. Also, MS-325 might enable the
use of a new approach in imaging mild or non-enhancing
tumors using conventional extracellular contrast agents [23].
It was administered in doses recommended by the manufac-
turer for standard examinations: MR angiography of abdom-
inal and lower extremity vessels—i.e., 0.12 ml/kg b.w.,
which is equal to 0.03 mmol/kg b.w.
After intravenous administration of the contrast medium,
a second T1-sensitive (run2) scan was performed using a
3D GRE sequence according to the following protocol:
FOV=228×228 mm, matrix=128×128, TR=2.6 ms, TE=
1.1 ms, FA=10°, iPAT=2, bandwidth=1185 Hz/Px, in-
plane resolution=1.78×1.78 mm. Forty slices in the axial
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One hundred and five volumes were acquired in TA=10′30.
The first five volumes were rejected so as to achieve stable
magnetization.
During the same session, a more comprehensive mor-
phology protocol was performed on 11 patients in order to
bring their radiological diagnoses up to date. For this
reason, functional CBV examinations were started immedi-
ately or up to 10 min after contrast agent administration.
The total time of each session did not exceed 60 min.
All subjects were trained to rehearse the paradigm task a
few minutes before the procedure. Each patient performed
between one and three paradigms. In cases where the
pathological mass was located near the central sulcus, the
finger tapping paradigm was used. In two of these cases,
touch stimuli were applied. The movement task required the
patient to freely move the fingers of his or her contralateral
hand in relation to the hemisphere with the tumor or post-
surgical lesions. Depending on the patient’s neurological
state, the movement they had to perform was either to touch
their thumb sequentially with fingers II, III, IV, and V, or to
clench and open their fist. In cases where touch stimuli
were used, the dorsum of the hand was stroked by an
experimenter using a coarse brush. For both the finger
tapping and the touch stimuli methods, each hand was
examined separately in order to evaluate secondary and
additional centers of activation.
Preprocessing Data was analyzed using statistical para-
metric mapping (SPM5) software (Wellcome Department
of Imaging Neuroscience, University College London,
London, UK). Movement correction was performed as
the first preprocessing step for the BOLD and T1 CBV
image series. All patients, with movements greater than
2 mm or correlations with stimulating paradigms bigger
than 0.5, were excluded from the study. Subsequently,
c o - r e g i s t r a t i o no fT 1a n dE P Iw a sp e r f o r m e di no r d e rt o
move two series in the same space and allow localization
of activated regions. Spatial smoothing of functional
images (Gauss smoothing filter with kernel FWHM=
7 mm) was used to compensate for residual distortion
between-subject variability after spatial normalization. A
128-s high-pass filter was applied to remove low-
frequency fluctuations in the BOLD response.
Modeling General linear modeling was used to set up a
model and to fit it to the acquired data. The model timing
was derived from individual subject performance logs.
Statistics Hot spot analyses were performed for individual
patients. For each voxel, a T value was calculated. Each
voxel with a T score above the threshold value was treated
as an active voxel, with the condition that within the nearest
vicinity were at least four “active voxels.”
Results
In both groups: for patients who had previously undergone
surgical procedures and those who had not, we observed an
increase in signal activity in the primary sensorimotor
cortex during both the BOLD contrast (—in 85.7% and
100% of tasks, respectively) and the T1 CBV techniques
(78.6% and 85.7% of tasks).
We found a high concordance in the localization of
activations between the two techniques. In the group of
patients before surgical intervention, this was confirmed in
No Initials Localization Tumor type Time between MRI and surgery in months surgery
MRI exam before surgery
1 KZ P/T left AG 1 Subtotal
2 MP F right PNET 2 Biopsy
3 KW F left PNET 1 Biopsy
MRI exam after surgery
4 EF F/T left M 10 Total
5 RC T left AF/GM 91 Partial
6 ZN P/O right meta colon 3 days Subtotal
7 MF P left AF/GM 1 Subtotal
8 WC F left ODG 3 days Total
9 EW F right AF 100 Total
10 AS P left OAA 10 Subtotal
11 MK F right HAP 68 Total
12 JS F left AF 11 Total
13 BC F left AF 10 Total
Table 1 Patients’ data regard-
ing localization, pathological
type of the tumor, and kind of
used neurosurgical procedure
AG Astrocytoma gemistocyti-
cum, PNET primitive neuroec-
todermal tumor, M meningioma,
AF Astrocytoma fibrillare, ODG
Oligodendroglioma, OAA Oli-
goastrocytoma anaplasticum,
HAP Haemangiopericytoma-like
tumor, F frontal lobe, T tempo-
ral lobe, P parietal lobe, O
occipital lobe
Neuroradiology (2011) 53:523–531 525all patients, in six out of seven tasks; in one case, massive
movement artifacts were observed during T1 CBV exam-
ination. In the post-surgical intervention group, we found
agreement in localization for nine out of the 14 performed
tasks. In two cases, signal loss occurred during the EPI
sequence due to the presence of postoperative materials,
which made it impossible to obtain any results using this
method. In one case, movement artifacts interfered with the
interpretation of the T1 CBVexamination, and two patients
did not show statistically significant activations in one of
their tasks (Table 2, Figs. 1, 2).
Using the BOLD technique, we found typical t values in
the activated areas ranging between 5.8 and 15. After
surgery, these remained similar, except in one subject who
failed to show activation at all. By comparison, using a
blood pool contrast agent and T1-weighted images, we
found t values between 3 and 9.4 before surgery, somewhat
reduced after surgery.
There were no significant differences in the t values for
the T2* EPI examinations between the pre- and post-
intervention patients in the same functional technique; the
mean value for acquired data was (after excluding tasks
with values=0 because of artifacts) 10.84 and 9.36,
respectively. For the T1 CBV technique, the mean t value
for the post-intervention patients was lower: 5.83 and 3.9,
respectively. However, this was the result of no activation
during the single tasks of two patients. None of the patients
demonstrated a lack of activation in the sensorimotor cortex
for all of the tasks.
We observed activation of the cerebellum in four patients
for six of the tasks using the BOLD technique. For the T1
CBV technique, activation in this area was observed in two
of the same patients for three tasks. The mean t values for
the BOLD and T1 CBV techniques were 8.3 and 3.9,
respectively. For the pre-intervention group, no areas of
activation were observed in the cerebellum for any of the
patients using the different methods (Fig. 3).
Discussion
Since the possibility of applying the T1 CBV technique was
previously demonstrated during laboratory studies and in
healthy volunteers [16], a control group was not included in
this study. Although their cohort was small, Ben Bashat et
al. [17] achieved satisfactory results during CBVevaluation
of brain tumor patients using routinely applied gadolinium
chelates with a mean distribution half-life of about 0.2 h
(www.imaging.bayerhealthcare.com/html/magnevist).
The results of our study confirmed the high value of the
tested procedure in patients qualified for neurosurgeries,
particularly in those who were already subjected to surgical
treatment. We observed increased signal intensity of the
primary motor cortex (PMC) in four out of five paradigms
applied to all three non-operated subjects, as well as in 12
out of 14 tasks performed by nine patients who were
subjected to neurosurgical intervention. When using the
T2* BOLD technique, an established and reliable source of
functional information, during the same session, the
activations were observed in all paradigms applied in
preoperative studies and in 12 out of 14 tasks performed
by all ten subjects who were examined postoperatively. The
lack of cortical center activation in T1 CBV sequences was
related to the presence of significant movement artifacts. In
T2* EPI sequences, the activation was not noted due to
signal loss caused by the presence of post-surgical
materials.
The possibility of examining patients who were previ-
ously subjected to neurosurgical procedures seems to be the
vital objective of T1 CBV technique application. Patients in
whom tumor relapse was suspected were frequently
disqualified from functional studies up to now. Using the
BOLD technique, fibrous or metallic structures left after
surgery disturbed or even disabled precise mapping of
surrounding cortical centers located in the region of
potential relapse. In this study, such a situation occurred
in two out of ten patients examined. In echo planar
sequences, signal loss was observed around the eloquent
centers of these patients due to CranioFixes placed in their
skulls. Significant, precisely located activations were
observed in these patients, however, when the T1 CBV
technique was applied (Fig. 4).
The presence of head movement artifacts in T2*
BOLD examinations, observed also in our results,
characterizes multi-shot techniques such as GRE. These
artifacts, especially task-related, can influence signifi-
cantly the examined cortex activities or/and create false
negative results. One of this important problem solutions
is to use single shot EPI by adding additional inversion
pulse in EPI sequence what gives additional T1 weight-
i n gt oT * 2E P Ii m a g e s[ 24, 25]. A common application of
Magnetization Prepared Rapid Gradient Echo (MP-
RAGE) is to provide precise anatomical references free
from the distortions and dropouts of the fast, low-
resolution, T*2-weighted images used to obtain functional
data. But one of our primary goals of this work was to use
high-quality structural brain MP-RAGE sequences for
functional imaging. A use of MP-RAGE also for func-
tional imaging overcomes several problems associated
with image co-registration and different T*2 weighting
specific to EPI sequence. We tuned our MP-RAGE
sequence with respect to two parameters: brain coverage
and volume acquisition time. Further studies with combi-
nation of EPI with inversion pulse in order to compare
performance either IR-EPI or MP-RAGE are necessary but
are beyond the scope of this paper.
526 Neuroradiology (2011) 53:523–531The motion artifacts present only in the CBV T1 may be due
to several factors. EPI sequences were used relatively early,
during the first phase of RM examination, prior to contrast agent
application.The T1CBVsequence was always the lastone used
in every patient. Since more than one paradigm was applied in
four out of ten patients, and morphological sequences were used
in all subjects also following contrast agent application, at the
end of the study, patients were likely tired and less concentrated.
Table 2 Values of T-statistics in PMC and CBL in used paradigms both in EPI BOLD and CBV T1 methods
No Initials Paradigm T statistic value
EPI BOLD CBV T1
PMC CBL ipsi/contr PMC CBL ipsi/contr
MRI exam before surgery
1 KZ right H movement 15.14 4.13
2 MP left H movement 5.81 5.67
right H movement 8.55 2.97
3 KW right H movement 9.23 9.41
left H movement 8.9 Massive artifacts
MRI exam before surgery
4 EF right H movement 11.24 4.28
5 RC right H movement 7.36 5.73
6 ZN right H movement 9.96 Massive artifacts
7 MF right H movement 8.84 8.83 4.45 3.43
right H sensory task 3.66 7.68 2.25 5.07
8 WC right H movement 6.17 5.69 3.94
9 EW left H movement 0 signal loss 4.99
10 AS right H movement 12.55 7.42 0
right H sensory task 3.47 3.55
11 MK left H movement 7.49 5.36
12 JS right H movement 12.55 11.74 5.18 3.27
left H movement 15.37 5.39/11.39 0
13 BC right H movement 0 signal loss 5.57
left H movement 13.22 5.6
H hand
Fig. 1 Patient KW before sur-
gery with tumor in the left frontal
lobe; activations in PMC in T1
CBV technique upper row, in
BOLD technique in lower row
during right-hand movement
Neuroradiology (2011) 53:523–531 527This was particularly the case of one of our female patients,
whose clinical status was poor due to surgery performed
3 days prior to MR examination. Additionally, the duration of
t h eT 1s e q u e n c ei sl o n ga n da m o u n t st o1 0m i na n d3 1s —
twice as long as for EPI (5 min 11 s)—another factor reflected
by patient fatigue. Secondly, the risk of movement artifact
occurrence elevates significantly with test of such long
duration. Thirdly, t values of cortical activities recorded by
means of the T1 CBV technique were significantly lower
compared to the BOLD contrast method; thus, cortical activity
m a yh a v eb e e nm a r k e d l ys u p p r e s sed, even by low-intensity
motion artifacts.
Additionally, our experience suggests the necessity for
creating a new method or significant modification of
existing processing methods of data obtained by means of
the T1 CBV technique. While the SPM statistical package
is being widely and effectively used in calculations related
to T2* BOLD examinations, it has significant limitations in
context of its application to T1 CBV results. The volume
subjected to analysis is one of the principal differences
between these two techniques. In order to accelerate
calculations performed with the SPM software, a mask is
determined for the points subjected to these calculations.
The points whose signal is close to zero are discarded from
Fig. 2 Patient EF after surgery with encefalomalacia areas in the left precentral gyrus and parietal lobe; activations in PMC in technique T1 CBV
upper row, in BOLD technique in lower row during RIGHT hand movement
Fig. 3 Patient MF after surgery;
activations in CBL in T1 CBV
technique upper row, in BOLD
technique in lower row during
right hand movement
528 Neuroradiology (2011) 53:523–531further analyses. Therefore, only the brain volume is
subjected to further analyses in the case of echo planar
imaging, compared to nearly the entire head, including
bones and skin tissues, in the case of T1 images.
Additionally, there is a risk of signal loss when examining
the ventricles and deep grooves, where depending on
individual morphology, signal intensity may be close to
zero.
Along with Morton’s findings [15], but opposite to the
results published by Ben Bashat et al. [17], we observed
that in 83.3% of cases, t values of activation were lower in
the T1 CBV technique. The results of functional T1 CBV
examinations are influenced by several factors, including
the type of paradigm applied, the intensity of magnetic
field, image noise due to voxel size, bandwidth, and type of
MR sequence as well as various t effects of head motion
[26]. Moreover, the sequences we used differed significant-
ly in terms of their resolution: the voxel sizes were 3.75 and
1.78 mm for T2* and T1 sequences, respectively. The
objective of our study was to compare two methods using
sequences which are widely available in MR examination
rooms. Nonetheless, simultaneously, we continue studies
with high-resolution T2* BOLD sequences.
Different ranges of t values for both methods compared
in this study seem to have no practical importance. The
groups we analyzed were small, particularly in the case of
subjects examined preoperatively. The group of subjects
after neurosurgeries was inhomogeneous in terms of post-
surgical area location, its shape and size, co-existing
softening and/or edema, type of surgery, and the presence
of potential relapse.
Similar to the BOLD contrast method, the T1 CBV
technique’sabilitytodetectactivationisnotlimitedtoprimary
sensorimotor centers. In our study, three tasks performed by
two subjects after surgeries revealed activation within the
cerebellar region as well. Similar to activations observed in
superior centers, t values obtained using the CBV technique
were lower compared to those revealed by the BOLD
contrast method. The possibility of determining functional
brain reorganization and plasticity processes in patients
subjected to neurosurgeries is particularly important—both
to fully understand these mechanisms and in context of
planning potential sparing re-surgeries.
Depending on the overall status of the patients, a
different number of paradigms, from 1 to 3, was applied
both for the EPI and T1 techniques. Clinical application of
blood pool contrast agents, probably the first in history, was
the factor which enabled performing the entire functional
examination procedure, including the required number of
paradigms. The blood concentration of these agents is
constant and they remain in circulation long enough for
standard fMRI procedures, with no need of additional doses
added every several minutes. Consequently, it is possible to
use additional diagnostic morphological sequences with the
same single dose of contrast agent, as was confirmed in our
study.
Similar to T2* BOLD, the sensitivity of T1 CBV
increased when more than one paradigm was applied [27,
Fig. 4 Patient BC after surgery with presence of cranio-fixes in the
left frontal lobe area; activations in PMC in a T1 CBV technique—
upper row, during right hand movement—red color, during left hand
movement—blue color. b in BOLD technique—lower row, during
right hand movement - no activation because of vast area of artifacts,
during left hand movement—yellow color
Neuroradiology (2011) 53:523–531 52928]. In one patient (AS), the location of the primary
sensorimotor center was established based on increased
signal intensity in the tactile paradigm, while no activity of
this center was observed during movement task.
The necessity for contrast agent application in T1 CBV
is undoubtedly its limitation compared to T2* BOLD,
making the former technique an invasive one. Nonetheless,
T1 CBV may be applied in cases where there are clinical
indications for the use of contrast agents, with suspicion of
tumor relapse being one of the cases where the use of
contrast agents is obligatory. In this study, we used Vasovist
agent at a dose recommended by its manufacturer for
standard examinations—MR angiography of abdominal and
lower limb vessels—i.e., 0.12 ml/kg b.w., which corre-
sponds to 0.03 mmol/kg b.w. Further research is needed to
determine if this dosage requires optimization in order to
improve signal acquisition during functional studies.
Contrary to Ben Bashat et al., we did not observe
activation around neoplastic tumors using the T1 CBV
technique. According to these authors, activation observed
around the tumor on T1 CBV images would suggest that
evaluation of angiogenesis is possible using this method
[17]. This would be another potential interesting application
of this new technique, but further research is needed to
optimize both the T1-weighted sequences dedicated to
functional examination and the distribution profile of the
contrast agent. As for the lack of activation around tumors
found in our study, this might be related to differences in
the microscopic structure of neoplasms we examined
compared to those analyzed by Ben Bashat et al. [17].
Conclusions
In conclusion, the T1 CBV technique can be used to detect
functional changes in the sensorimotor cortex of patients with
brain tumors, both before and after surgical intervention. The
centers of activation in both the BOLD and T1 CBV
techniques have the same localization; however, the increase
in signal intensity was lower for the T1 CBV technique.
Therefore, this technique is more sensitive to movement
artifacts. The T1 CBV technique enables accurate evaluation
of cortical centers, which is usually disturbed when using the
BOLD method due to magnetic susceptibility artifacts.
Clinical application of the T1 CBV technique requires
improved methods of data collection and analysis, as well as
determination of correct dosages of contrast agent.
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